Ursolic acid treatment leads to CHOP-mediated upregulation of DR5, making cancer cells more sensitive to the cytotoxic activity of TRAIL, improving the efficiency of TRAIL-induced apoptosis in cancer cells [86]. The gene discussed is TNFSF10; the disease is cancer.